Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Equity (2016 - 2025)

Historic Return on Equity for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to 0.3%.

  • Agios Pharmaceuticals' Return on Equity fell 8900.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 8900.0%. This contributed to the annual value of 0.57% for FY2024, which is N/A changed from last year.
  • Per Agios Pharmaceuticals' latest filing, its Return on Equity stood at 0.3% for Q3 2025, which was down 8900.0% from 0.46% recorded in Q2 2025.
  • Agios Pharmaceuticals' 5-year Return on Equity high stood at 1.46% for Q4 2021, and its period low was 0.52% during Q2 2024.
  • Over the past 5 years, Agios Pharmaceuticals' median Return on Equity value was 0.0% (recorded in 2022), while the average stood at 0.27%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 18600bps in 2021, then crashed by -14300bps in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Equity (Quarter) stood at 1.46% in 2021, then tumbled by -100bps to 0.0% in 2022, then tumbled by -11596bps to 0.42% in 2023, then skyrocketed by 201bps to 0.42% in 2024, then crashed by -172bps to 0.3% in 2025.
  • Its last three reported values are 0.3% in Q3 2025, 0.46% for Q2 2025, and 0.44% during Q1 2025.